Precision Medicine Quarterly

New NASEM Report Suggests Dropping Race, Ethnicity Tags From Genetic, Genomic Studies

2023-03-15T08:16:03-05:00March 15th, 2023|

Researchers should reconsider how they use population descriptors such as race, ethnicity, and geographic location in genomic and genetic research, according to a new report from the US National Academies of Sciences, Engineering, and Medicine. The report, commissioned by the National Institutes of Health, says population descriptors do not fully capture the range of [...]

New Single-Cell Genome, Transcriptome Sequencing Technique Delivers Better Bang For Buck

2023-03-15T08:07:05-05:00March 15th, 2023|

A scalable and low-cost way to perform genome and transcriptome sequencing (G&T-seq) of single cells without upfront whole-genome amplification (WGA) is being developed at Belgium's KU Leuven. The method, called Gtag&T-seq (Gtag), combines G&T-seq with tagmentation. Researchers from the lab of Thierry Voet at KU Leuven used it to improve coverage uniformity, lower selection [...]

Sophia Genetics, Agilent Partner on Cancer Analysis Product

2023-03-15T08:05:17-05:00March 15th, 2023|

Sophia Genetics said Tuesday that it is integrating its DDM bioinformatics platform with Agilent Technologies' recently released SureSelect Cancer Comprehensive Genomic Profiling (CGP) assay kit. By bringing together Sophia's analytics with Agilent's target enrichment and next-generation sequencing-based assay technology, the firms hope this partnership will help cancer researchers improve identification of multiple biomarkers. "We [...]

Polygenic Risk Score, AI Tool May Help Patients Reduce Inherited Heart Disease Risk, Study Suggests

2023-03-08T08:33:57-05:00March 8th, 2023|

An artificial intelligence tool paired with a polygenic risk score (PRS) can quantify steps for patients to take to curb their inherited risk of coronary artery disease, according to late-breaking clinical trial results shared Sunday at the American College of Cardiology (ACC) and World Congress of Cardiology's annual scientific meeting. Study authors from the [...]

MolDx Reimbursement Decision Likely to Have Negative Impact on CareDx, Natera Transplant Businesses

2023-03-08T08:25:21-05:00March 8th, 2023|

Palmetto MolDx updated its reimbursement guidance for molecular tests assessing rejection risk in solid organs with more restrictive language concerning appropriate use and testing frequency, a decision that could have negative implications for CareDx and Natera. A Billing Article effective March 31 limits reimbursement to one test per patient encounter, provides new coding to [...]

VieCure, Exact Sciences Partner to Ease Genomic Testing Access, Interpretation

2023-03-08T08:22:20-05:00March 8th, 2023|

Informatics and clinical decision support firm VieCure said Monday that it has entered a strategic collaboration with Exact Sciences aimed at improving access to precision oncology diagnostics for US patients and community oncologists. Under the agreement, Denver-based VieCure will integrate Exact Sciences’ portfolio of diagnostic tests —beginning with the Oncotype DX breast cancer recurrence [...]

Sophia Genetics Q4 Revenues Grow 23 Percent on Strong Data Analysis Sales

2023-03-08T08:20:04-05:00March 8th, 2023|

Sophia Genetics said Tuesday before market opening that its 2022 fourth quarter revenues grew 23 percent to $13.4 million from $10.9 million a year earlier, beating analysts' average estimate of $12.9 million. On a constant currency basis, revenues grew 36 percent, while constant currency revenue growth excluding COVID-19-related revenue was 44 percent. The Swiss [...]

Go to Top